logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11655235 B1

PDFFull Text
Date of Patent:
May. 23, 2023

Filed:

Nov. 05, 2020

Pyrrolidine and piperidine compounds

Applicant:

Yuhan Corporation, Seoul, KR;

Inventors:

Tae Han Dong, Yongin-si, KR;

Yoo Hoi Park, Suwon-si, KR;

Tae Kyun Kim, Hwaseong-si, KR;

Jae Eun Joo, Yongin-si, KR;

Eun Hye Jung, Yongin-si, KR;

Jae Won Jeong, Hwaseong-si, KR;

Hyun Seung Lee, Yongin-si, KR;

Do Hoon Kim, Yongin-si, KR;

Ji Eun Yang, Yongin-si, KR;

Jun Chui Park, Yongin-si, KR;

Sang Myoun Lim, Seoul, KR;

Na Ry Ha, Seoul, KR;

Da In Chung, Seoul, KR;

Ji Yeong Gal, Suwon-si, KR;

Assignee:

YUHAN CORPORATION, Seoul, KR;

Attorney:

Sheppard Mullin Richter & Hampton LLP

Primary Examiner:

Amanda L Aguirre

Int. Cl.
CPC ...
A61P 1/16 (2006.01); A61P 35/00 (2006.01); C07D 207/16 (2006.01); C07D 401/14 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 491/048 (2006.01); C07D 495/04 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/5377 (2006.01); A61K 31/4725 (2006.01); A61K 31/519 (2006.01); A61K 31/423 (2006.01); A61K 31/517 (2006.01); A61K 31/4365 (2006.01); A61K 31/4025 (2006.01); A61K 31/4355 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 207/16 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); A61K 31/4025 (2013.01); A61K 31/423 (2013.01); A61K 31/4355 (2013.01); A61K 31/4365 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61P 1/16 (2018.01); A61P 35/00 (2018.01);
Abstract

The present technology provides pyrrolidine and piperidine compounds or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. In particular, said compounds may be usefully applied in the treatment and prevention of FAP-mediated diseases.

Find Patent Forward Citations

Loading…